Importantly, downregulating UQCRB also impairs cancer stem cell-like traits in glioblastoma by reducing c-Met signaling, HIF-1α activation, and mitochondrial membrane potential, highlighting its potential in combating tumor recurrence and angiogenic niches [86]. This evidence concerns the gene HIF1A and neoplasm.